Fibulink Syndesmosis Repair System With Early Full-Weight Bearing
Launched by MAIMONIDES MEDICAL CENTER · Oct 10, 2023
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device called the Fibulink Syndesmosis Repair System, which is designed to help fix certain types of ankle fractures and injuries. Specifically, the trial aims to see how well this system can keep the bones in the ankle stable after surgery, which is really important to prevent future problems like arthritis. A key part of this study is to test if patients can start putting their full weight on the injured ankle earlier—just four weeks after surgery—while wearing a special boot. This is a significant improvement because current methods often require patients to wait longer, which can slow down recovery.
To be eligible for this study, participants must have specific types of ankle fractures that involve disruption of the syndesmosis, which is the fibrous joint connecting the two bones in the lower leg. Examples include bimalleolar ankle fractures and Maisonneuve fractures. However, people with previous ankle surgeries, infections, certain chronic conditions, or who are pregnant cannot participate. If someone joins the study, they can expect close monitoring and support as they recover, contributing to important research that could improve ankle injury treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ankle fracture with syndesmotic disruption as assessed with intra-operative cotton test.
- This includes the following injuries:
- • Syndesmotic sprain (without fractures)
- • Bimalleolar equivalent ankle fractures
- • Bimalleolar ankle fractures
- • Maisonneuve fractures
- • Trimalleolar ankle fractures without the need for posterior malleolus fixation
- • Ankle fracture dislocations
- Exclusion Criteria:
- • 1) previous ankle surgery, 2) active local infection about the ankle, 3) chronic ankle deformity secondary to trauma or congenital, 4) ligamentous laxity, 5) pathologic fractures, 6) peripheral vascular disease, 7) peripheral neuropathy, 8) diabetes neuropathy and charcot, 9) open fractures, 10) poly trauma, 11) inability to provide informed consent, 12) symptomatic ankle osteoarthritis, 12) retained hardware, 13) pregnant, 14) metabolic bone disease, 15) history of chronic steroid use, 16) mal-reduced ankle fractures
About Maimonides Medical Center
Maimonides Medical Center is a leading healthcare institution located in Brooklyn, New York, renowned for its commitment to patient-centered care and innovative medical research. As a prominent clinical trial sponsor, Maimonides Medical Center leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center collaborates with a diverse team of healthcare professionals and researchers to conduct rigorous clinical trials across various specialties, ensuring adherence to the highest ethical standards and regulatory guidelines. Through its dedication to clinical excellence and community health, Maimonides Medical Center plays a vital role in translating research findings into practical, life-saving treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brooklyn, New York, United States
Patients applied
Trial Officials
Amr A Abdelgawad, MD PhD MBA
Principal Investigator
Vice Chair of Orthopedic Clinical Programs, Director of Pediatric Orthopedic Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported